41 related articles for article (PubMed ID: 8891598)
21. Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor.
Gether U; Johansen TE; Snider RM; Lowe JA; Emonds-Alt X; Yokota Y; Nakanishi S; Schwartz TW
Regul Pept; 1993 Jul; 46(1-2):49-58. PubMed ID: 7692567
[No Abstract] [Full Text] [Related]
22. Tachykinin NK
Jung HJ; Priefer R
Auton Neurosci; 2021 Nov; 235():102865. PubMed ID: 34358844
[TBL] [Abstract][Full Text] [Related]
23. Non-neuronal mammalian tachykinin expression.
Nelson DA; Bost KL
Front Biosci; 2004 Sep; 9():2166-76. PubMed ID: 15353278
[TBL] [Abstract][Full Text] [Related]
24. The study of tachykinin receptors.
Burcher E
Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):539-43. PubMed ID: 2548782
[TBL] [Abstract][Full Text] [Related]
25. Tachykinin receptors in the gut: physiological and pathological implications.
Holzer P; Holzer-Petsche U
Curr Opin Pharmacol; 2001 Dec; 1(6):583-90. PubMed ID: 11757813
[TBL] [Abstract][Full Text] [Related]
26. Comparison of binding assay and biological activity on a NK-1 system with new selective agonists.
Tousignant C; Guillemette G; Drapeau G; Regoli D
Neuropeptides; 1989; 14(4):275-83. PubMed ID: 2482952
[TBL] [Abstract][Full Text] [Related]
27. Tachykinin receptors and the airways.
Frossard N; Advenier C
Life Sci; 1991; 49(26):1941-53. PubMed ID: 1660952
[TBL] [Abstract][Full Text] [Related]
28. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough.
Advenier C; Lagente V; Boichot E
Eur Respir J; 1997 Aug; 10(8):1892-906. PubMed ID: 9272936
[TBL] [Abstract][Full Text] [Related]
29. Substance P: a pioneer amongst neuropeptides.
Hökfelt T; Pernow B; Wahren J
J Intern Med; 2001 Jan; 249(1):27-40. PubMed ID: 11168782
[TBL] [Abstract][Full Text] [Related]
30. Tachykinins in the respiratory tract.
Groneberg DA; Harrison S; Dinh QT; Geppetti P; Fischer A
Curr Drug Targets; 2006 Aug; 7(8):1005-10. PubMed ID: 16918328
[TBL] [Abstract][Full Text] [Related]
31. Tachykinin-mediated modulation of the immune response.
Bost KL
Front Biosci; 2004 Sep; 9():3331-2. PubMed ID: 15358592
[TBL] [Abstract][Full Text] [Related]
32. The role of tachykinins on bacterial infections.
Pascual DW
Front Biosci; 2004 Sep; 9():3209-17. PubMed ID: 15353350
[TBL] [Abstract][Full Text] [Related]
33. Tachykinin receptors antagonism for asthma: a systematic review.
Ramalho R; Soares R; Couto N; Moreira A
BMC Pulm Med; 2011 Aug; 11():41. PubMed ID: 21810226
[TBL] [Abstract][Full Text] [Related]
34. Mapping the ligand binding site of the NK-1 receptor.
Fong TM; Huang RR; Yu H; Strader CD
Regul Pept; 1993 Jul; 46(1-2):43-8. PubMed ID: 8210503
[No Abstract] [Full Text] [Related]
35. Tachykinin-modulated anti-viral responses.
Bost KL
Front Biosci; 2004 Sep; 9():1994-8. PubMed ID: 15353265
[TBL] [Abstract][Full Text] [Related]
36. The dual nature of the tachykinin NK1 receptor.
Maggi CA; Schwartz TW
Trends Pharmacol Sci; 1997 Oct; 18(10):351-5. PubMed ID: 9357319
[No Abstract] [Full Text] [Related]
37. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
Strigas J; Burcher E
Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
[TBL] [Abstract][Full Text] [Related]
38. Species variants of tachykinin receptor types.
Watling KJ; Guard S; Boyle SJ; McKnight AT; Woodruff GN
Biochem Soc Trans; 1994 Feb; 22(1):118-22. PubMed ID: 7515828
[No Abstract] [Full Text] [Related]
39. Tachykinins in the gut. Part I. Expression, release and motor function.
Holzer P; Holzer-Petsche U
Pharmacol Ther; 1997; 73(3):173-217. PubMed ID: 9175155
[TBL] [Abstract][Full Text] [Related]
40. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.
Ganjiwale A; Cowsik SM
Mini Rev Med Chem; 2013 Dec; 13(14):2036-46. PubMed ID: 23937231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
